CLINICAL_TRIALS
trial_result
· 2018-10-01
Clinical Trial Update: Novel Use Of Hydroxyurea in an African Region With Malaria [Phase 3]
Summary
Phase 3 trial assessing novel use of hydroxyurea in Africans with sickle cell disease; results completed and posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Sickle Cell Anemia, Sickle Cell Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-10-01